Global Gynecology Devices Market to Reach US$ 23.1 Billion by 2032, Propelled by Rising Prevalence of Numerous Gynecological Conditions

According to the latest report by IMARC Group, titled “Gynecology Devices Market Report by Product (Surgical Devices, Hand Instruments, and Others), End Use (Hospitals and Clinics, Diagnostic Centers, and Others), and Region 2024-2032”, the global gynecology devices market size reached US$ 12.8 Billion in 2023. Gynecology devices refer to surgical and monitoring devices used for the detection and treatment of numerous health conditions and disorders associated with female reproductive organs, including the vulva, ovaries, uterus and breasts. These tools or equipment are used to perform certain activities or produce desired results, such as changing biological tissue or allowing access to observe it, during a surgery or operation. Some gynecology devices are compatible with general surgery, while others are designed specifically for some particular treatments. There is a wide range of sizes and design options in gynecology devices to meet the specific needs of a patient. They are available in both coated and uncoated steel variants to provide maximum comfort as well as productivity. These devices generally facilitate colposcopy, loop tubal ligation, endometrial biopsy, ovarian cystectomy, electrical excision procedure (LEEP), intrauterine device (IUD) insertion, and dilation and curettage (D&C).

Global Gynecology Devices Market Trends:

The global market is majorly driven by the augmenting need for durable and easy autoclavable surgical instruments. This can be attributed to a considerable rise in the prevalence of gynecological conditions, such as cervical cancer, polycystic ovary syndrome, and vaginal melanoma, among women. In addition to this, a paradigm shift toward comprehensive approaches, including prevention, early diagnosis, effective screening, and treatment programs, is providing an impetus to the market. Moreover, the escalating demand for advanced gynecology devices that aid in increasing the efficiency of minimally invasive (MI) surgical procedures and reducing operating time is propelling the product demand. Apart from this, the incorporation of advanced technologies, such as robotics and artificial intelligence (AI), for automating gynecological surgeries is also creating lucrative growth opportunities in the market. The market is further fueled by the rapid utilization of definition imaging devices, such as three-dimensional (3D) endoscopes, in numerous gynecology procedures. Additionally, favorable initiatives undertaken by government of several countries for increasing the number of hospitals offering gynecology services as well as improving the services in existing ones are creating a positive market outlook. Some of the other factors contributing to the market include the growing awareness regarding women health, rising medical expenditure, and extensive research and development (R&D) activities. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 23.1 Billion by 2032, exhibiting a CAGR of 6.6% during 2024-2032.

Market Summary:

• Based on the product, the market has been segmented into surgical devices (gynecological endoscopy devices - hysteroscope, colposcope, resectoscope, laparoscope and endoscopic imaging systems; endometrial ablation devices - hydrothermal ablation devices, radiofrequency ablation devices, balloon ablation devices, and others; fluid management systems; and female sterilization/contraceptive devices - permanent birth control, intra uterine devices (IUD), intravaginal rings, and subdermal contraceptive implants), hand instruments (vaginal speculum, tenaculum, curettes, trocars, biopsy forceps, and others), and others.
• On the basis of the end use, the market has been classified into hospitals and clinics, diagnostic centers, and others.
• On the geographical front, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
• The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Boston Scientific Corporation, CooperSurgical Inc., Fresenius Medical Care AG & Co. KGAA, General Electric Company, Hologic Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens AG, and Stryker Corporation.
   

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800